Our goal at IGBS is to assist organizations increase the value of their technology at each stage of the development process in a way that reduces investment risk and maximizes development success. Our fundamental understanding of how initial, early-stage development decisions greatly impact the downstream regulatory requirements is the core of our business. IGBS will aid your organization in taking the appropriate development steps and evaluating the risks and potential return at each stage of development. The experience IGBS has with successful early-stage bioscience companies enables us to understand the financial, structural and procedural challenges associated with the clinical development and commercialization of promising technologies. We fully appreciate the financial burn-rate inherent in the development process, as well as the importance of selecting clinical development partners who understand the unique challenges and culture of early-stage organizations. IGBS provides the strategic and regulatory planning necessary to engage potential investors and, once funding is obtained, IGBS implements development plans to meet both immediate and future regulatory requirements necessary to obtain FDA marketing approval.